NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.88% | -6.27% | -1.25% | 1.75% | -2.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.77% | -8.57% | -4.80% | -8.76% | -14.42% |
| Operating Income | -9.77% | 8.57% | 4.80% | 8.76% | 14.42% |
| Income Before Tax | -125.63% | -115.48% | -131.18% | 244.02% | 227.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -125.63% | -115.48% | -131.18% | 244.02% | 227.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -125.63% | -115.48% | -131.18% | 244.02% | 227.97% |
| EBIT | -9.77% | 8.57% | 4.80% | 8.76% | 14.42% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -125.51% | -115.35% | -131.13% | 244.56% | 228.65% |
| Normalized Basic EPS | 36.84% | 56.98% | 26.21% | -11.67% | -26.67% |
| EPS Diluted | -125.51% | -115.35% | -131.13% | 244.56% | 228.65% |
| Normalized Diluted EPS | 36.84% | 56.98% | 26.21% | -11.67% | -26.67% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |